These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 35278461

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
    Zheng CH, Chen XM, Zhang FB, Zhao C, Tu SS.
    Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
    [Abstract] [Full Text] [Related]

  • 26. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition.
    Miao L, Zhu S, Wang Y, Li Y, Ding J, Dai J, Cai H, Zhang D, Song Y.
    Med Oncol; 2013 Sep; 30(3):626. PubMed ID: 23761027
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Baicalin, a Chinese Herbal Medicine, Inhibits the Proliferation and Migration of Human Non-Small Cell Lung Carcinoma (NSCLC) Cells, A549 and H1299, by Activating the SIRT1/AMPK Signaling Pathway.
    You J, Cheng J, Yu B, Duan C, Peng J.
    Med Sci Monit; 2018 Apr 10; 24():2126-2133. PubMed ID: 29632297
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y, Xiao G, Chen Y, Deng Y.
    Anticancer Drugs; 2018 Sep 10; 29(8):725-735. PubMed ID: 29916897
    [Abstract] [Full Text] [Related]

  • 31. Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells.
    Jeon MJ, Kim WG, Lim S, Choi HJ, Sim S, Kim TY, Shong YK, Kim WB.
    Mol Cell Endocrinol; 2016 Jan 05; 419():113-23. PubMed ID: 26463583
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma.
    Dong L, Xie L, Li M, Dai H, Wang X, Wang P, Zhang Q, Liu W, Hu X, Zhao M.
    Sci Rep; 2019 Oct 16; 9(1):14854. PubMed ID: 31619714
    [Abstract] [Full Text] [Related]

  • 34. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ, Wei FK, Xu XL, Ye SX, Song JW, Ding PK, Zhu J, Li HF, Luo XP, Gong H, Su L, Yang L, Gong LY.
    J Transl Med; 2019 May 06; 17(1):143. PubMed ID: 31060551
    [Abstract] [Full Text] [Related]

  • 35. miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer.
    Yuan Y, Liao H, Pu Q, Ke X, Hu X, Ma Y, Luo X, Jiang Q, Gong Y, Wu M, Liu L, Zhu W.
    Signal Transduct Target Ther; 2020 Jun 12; 5(1):85. PubMed ID: 32528035
    [Abstract] [Full Text] [Related]

  • 36. Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma.
    Xie N, Cai JB, Zhang L, Zhang PF, Shen YH, Yang X, Lu JC, Gao DM, Kang Q, Liu LX, Zhang C, Huang XY, Zou H, Zhang XY, Song ZJ, Sun HX, Fu BM, Ke AW, Shi GM.
    Cell Death Dis; 2017 Dec 13; 8(12):3205. PubMed ID: 29235470
    [Abstract] [Full Text] [Related]

  • 37. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
    Zhang X, Cai L, Zhang G, Shen Y, Huang J.
    Oncotarget; 2017 Mar 21; 8(12):18861-18871. PubMed ID: 28061481
    [Abstract] [Full Text] [Related]

  • 38. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X, Ning J, Geng Q, Wang C, Hu Y, Li M, Niu W, Li E, Wu Y.
    Oncotarget; 2017 Jun 13; 8(24):38825-38840. PubMed ID: 28418915
    [Abstract] [Full Text] [Related]

  • 39. FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.
    Zhang Y, Zhang X, Ye M, Jing P, Xiong J, Han Z, Kong J, Li M, Lai X, Chang N, Zhang J, Zhang J.
    Cancer Lett; 2018 Apr 10; 419():75-83. PubMed ID: 29355657
    [Abstract] [Full Text] [Related]

  • 40. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
    Liu MX, Zhou KC, Cao Y.
    Mol Cancer; 2014 Nov 06; 13():245. PubMed ID: 25373388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.